DUBLIN, Dec 8, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the
"Global Gynecology Robotic Surgery Market 2016-2020" report to
their offering.
The global gynecology robotic surgery market to grow at a CAGR
of 10.07% during the period 2016-2020.
At present, the market is dominated by Intuitive Surgical due to
its da Vinci surgical system, though there is intense competition
between Titan Medical that developed the SPORT surgical system and
Intuitive Surgical. Titan Medical has a high market share in
Europe, and it is expected to
penetrate the US market by mid-2017 by getting approval for its
SPORT surgical system. TransEnterix has developed the ALF-X robotic
surgical system, which it acquired in September 2015 through the acquisition of a
robotic division of SOFAR S.p.a worth $99.8
million. The company also developed TELELAP ALF-X surgical
robotic system, a CE-marked device available in Europe.
The cost of capital equipment increases the cost burden on end
users. Hence, companies are coating competitive pricing to increase
their market adoption. For instance, hospital saving is one of the
key factors that every individual will look for. Hence, the
companies are trying to reduce the cost of the robotic platform
which in turn decreases the cost of treatment.
According to the report, the limitations involved in open surgeries
have driven the adoption of gynecological surgical robots. The open
abdomen surgery for gynecology and laparoscopic surgeries require
large incisions and longer recovery times, which affect the
individual's outcome. Also, the procedure is associated with the
increased infection rates and increased blood transfusion rates.
Therefore, the surgeons are increasingly adopting surgical robots
owing to its benefits over open surgeries. Some of the advantages
of surgical robots include, reduction of incision size, fewer blood
transfusions, and improved recovery times. Further, the robotic
surgery enhances surgeon's skills, reduces variability, and
provides opportunities for simulation.
Further, the report states that globally, end-users are gradually
adopting robotic treatments in the healthcare sector. The adoption
of robotic systems is better in developed countries of the Americas
and EMEA. However, the surgeons in developing and emerging
countries are still reluctant to choose robotic surgeries. Indeed,
the advances in medical robotic systems have increased the prices
of these devices, making treatments unaffordable for most patients
in developing economies. The device costs approximately
$1.50-$3 million depending on the
configurations.
Key vendors
- Intuitive Surgical
- Titan Medical
- TransEnterix
Other prominent vendors
- AVRA Surgical Robotics
- NovaTract Surgical
- OmniGuide Holdings
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Market landscape
Part 06: Market segmentation by product
Part 07: Market segmentation by applications
Part 08: Market segmentation by end-users
Part 09: Geographical segmentation
Part 10: Market drivers
Part 11: Impact of drivers
Part 12: Market challenges
Part 13: Impact of drivers and challenges
Part 14: Market trends
Part 15: Vendor landscape
Part 16: Key vendor analysis
Part 17: Appendix
For more information about this report visit
http://www.researchandmarkets.com/research/ms597j/global_gynecology
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716